Pyridostigmine Bromide
NDC 69238-1731, Pyridostigmine Bromide, solution, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-1731
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212702
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE60 mg/5mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-1731-2 | 69238173102 | 473 mL in 1 BOTTLE (69238-1731-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9c3a5abf-e217-4292-a305-5afd12b99e95NADAC price for package 69238173102
GET /v1/drugs/nadac/69238173102
Use it
Look up 69238-1731 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-1731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.